Author:

Dale W Stovall, MD
Section Editor:
William J Mann, Jr, MD
Deputy Editor:
Sandy J Falk, MD, FACOG
Contributor Disclosures

All topics are updated as new evidence becomes available and our peer review process is
complete.
Literature review current through: Oct 2016. | This topic last updated: Jun 03, 2015.
INTRODUCTION The gynecologist has a variety of tools available for evaluation and
treatment of women with abnormal uterine bleeding. Dilation and curettage (D&C) will be
reviewed here. Office procedures for endometrial sampling and an overview of diagnostic
approaches to endometrial evaluation, including both noninvasive and invasive assessment, are
discussed separately. (See "Endometrial sampling procedures" and "Evaluation of the
endometrium for malignant or premalignant disease".)
INDICATIONS D&C has both diagnostic and therapeutic indications.
Diagnostic indications The development of equipment and techniques for office based
endometrial sampling has obviated the need for diagnostic D&C in most patients. Numerous
studies have shown that the endometrium is adequately evaluated with sampling techniques.
(See "Endometrial sampling procedures".)
However, there are still some indications for diagnostic D&C, such as in women:
With a nondiagnostic office biopsy who are at high risk of endometrial carcinoma. (See
"Endometrial carcinoma: Epidemiology and risk factors", section on 'Risk factors'.)
With endometrial hyperplasia, and in whom endometrial cancer needs to be excluded.
(See "Classification and diagnosis of endometrial hyperplasia".)
With insufficient tissue for analysis on office biopsy.
In whom cervical stenosis prevents the completion of an office biopsy.

For whom another operative procedure, such as hysteroscopy or laparoscopy, is

deemed necessary.
Diagnostic D&C should be done with hysteroscopy to obtain a visual image of the endometrial
cavity and to exclude focal disease. Hysteroscopy thus turns a "blind" procedure into one
allowing directed curettage. This helps to prevent missing unsuspected polyps and insures that
the most visibly abnormal areas are sampled. (See "Overview of hysteroscopy".)
Therapeutic indications Dilation and evacuation/curettage (D&EC) is used as a therapeutic
modality in the following clinical settings:
Treatment of incomplete, inevitable, missed, septic, and induced abortions. (See
"Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic
evaluation" and "Surgical termination of pregnancy: First trimester".)
Initial treatment of molar pregnancies. (See "Initial management of low-risk gestational
trophoblastic neoplasia".)
Temporary management of women with prolonged or excessive vaginal bleeding
unresponsive to hormonal therapy. (See "Managing an episode of severe or prolonged
uterine bleeding", section on 'Uterine curettage'.)
Suction curettage (without dilation) may be used to manage postpartum hemorrhage
due to retained products of conception. (See "Overview of postpartum hemorrhage".)
CONTRAINDICATIONS The only major contraindication to D&C is a viable and desired
intrauterine pregnancy. Bleeding diathesis is a relative contraindication since bleeding may be
excessive in such patients. The management of these patients, including temporarily withholding
anticoagulants, needs to be decided on a case-by-case basis in consultation with the patient's
other physicians. In the presence of acute vaginal, cervical, or pelvic infection, the procedure
should be deferred, if possible, until the infection has been treated. One exception is therapeutic
D&C to remove infected products of conception. Cervical cancer, if obstructing the endocervical
canal, also represents a contraindication as heavy bleeding or perforation may occur. In these
patients cervical biopsy would be diagnostic and D&C would be unnecessary.

PREOPERATIVE PREPARATION D&C is generally performed under general or regional

anesthesia; therefore, the patient should limit oral intake prior to the procedure. The American
Society of Anesthesiologists recommends no intake of clear liquids in the two hours before and
no solid food in the six hours before procedures involving anesthesia (eight hours in pregnant
women) [1]. An empty stomach is also desirable for patients who plan paracervical block
anesthesia in case the block is inadequate and another anesthetic or sedative needs to be
administered.
Prophylactic antibiotics are not necessary.
Preoperative laboratory tests are generally not necessary, except as indicated by the patient's
age and medical condition. (See "Preoperative medical evaluation of the adult healthy patient",
section on 'Laboratory evaluation'.)
ANESTHESIA General, regional, or paracervical block anesthesia can be used. The type of
anesthesia chosen depends upon the indication for the procedure, as well as the medical history
of the patient. General anesthesia provides complete muscular relaxation, which is important
when examination under anesthesia is a critical element of the procedure. Regional anesthesia
provides adequate muscular blockade without the pulmonary and gastrointestinal risks of
general anesthesia.
Paracervical block with intravenous conscious sedation is a convenient, inexpensive, and
effective technique amenable to the outpatient setting (picture 1). The block anesthetizes uterine
nerves as they pass through Frankenhauser's plexus in the cervix. Chloroprocaine 1 percent
(Nesacaine) provides an improved margin of safety over lidocaine because it is rapidly
metabolized and theoretically has a lower risk of toxicity if an inadvertent intravascular injection
occurs. (See "Overview of pregnancy termination", section on 'Paracervical block'.)
There have been a number of randomized controlled trials comparing the analgesic effects of
intrauterine instillation of anesthetics (eg, 3 to 5 mL of 2 percent lidocaine or 2 percent
mepivacaine) versus placebo. Although about half of the trials showed that topical anesthesia

significantly reduced the patient's perception of pain during an intrauterine procedure [2-7], the
other half did not [8-12].
PROCEDURE
General issues A D&C is performed with the patient in the dorsal lithotomy position. Care
must be taken to avoid over-abduction of the hip joint when placing her in stirrups. Furthermore,
the lateral aspect of the legs should not rest against the stirrups as this can cause peroneal
nerve injury with subsequent foot-drop. (See "Nerve injury associated with pelvic surgery".)
An examination under anesthesia is performed first. (See "Pelvic examination under
anesthesia".) The size, shape, and position of the uterus are noted, with particular attention to
the axis of the cervix and flexion of the fundus. Appreciation of the latter is critical to reduce the
incidence of uterine perforation. The size, shape, and consistency of the adnexa are determined
next.
After the examination, the perineum, vulva, vagina, and cervix are cleansed with an aseptic
solution and drapes are placed; it is not necessary to shave either vulvar or lower abdominal
hair.
Exposure Vaginal retractors or a speculum is inserted into the vagina to provide exposure.
The type of vaginal retraction required for adequate exposure depends upon the woman's body
habitus and the procedure being performed. The Graves speculum provides adequate exposure
of the cervix and is well-suited for women undergoing a therapeutic D&C or dilation and
evacuation (D&E).
When a hysteroscopy is being performed in conjunction with the D&C, a side-open Graves
speculum provides excellent range of motion for the hysteroscope during the examination and
can be easily removed if additional range of motion is required. Alternatively, a Sims retractor or
an Auvard weighted speculum (figure 1) can be used in conjunction with Schieden vaginal side
wall retractors (picture 2). (See "Surgical instruments for gynecologic surgery".)

Tenaculum A tenaculum is generally used to grasp the anterior lip of the cervix (picture 3).
The single tooth tenaculum is useful in women with a small amount of cervical tissue (eg,
postmenopausal women, women who have undergone previous cone biopsy); however, this
instrument is more likely to cause a laceration of the cervix. We prefer the Bierer (multi-toothed)
tenaculum because it is less traumatic. Ring forceps may also be used to grasp the cervix,
particularly in the pregnant patient in whom the soft, engorged cervix is prone to laceration and
hemorrhage. In some patients, such as women with a lacerated or torn anterior lip, it will be
necessary to attach the tenaculum to the posterior cervical lip.
Endocervical curettage If indicated, an endocervical curettage (ECC) is performed before
dilation of the cervix to avoid contamination of the histologic specimen with endometrial cells. A
Kevorkian-Younge curette is introduced into the cervical canal up to the internal os (picture 4).
This instrument is slightly curved and narrow to accommodate the small endocervical canal. All
four quadrants of the canal are scraped and the specimen placed on a pad (eg, Telfa).
The ECC is performed to detect the presence of endometrial carcinoma extending into the
cervical canal or the presence of endocervical pathology. The clinical usefulness of the ECC has
been questioned. It is predictive of cervical involvement of endometrial carcinoma when the
histology demonstrates stromal involvement. However, numerous investigators have
demonstrated a false-positive rate of 80 percent when tumor is detected on ECC alone [13].
Since surgical staging of endometrial carcinoma does not require a separate ECC, the need for
an ECC is only relevant for patients who cannot undergo a full staging procedure. If there is a
clinical indication for D&C at the time of a cervical conization, the conization should be
performed prior to the D&C to avoid contaminating the cervical specimen with endometrial cells.
(See "Endometrial carcinoma: Epidemiology and risk factors".)
Sounding Traction is applied to the tenaculum to align the axis of the cervix and the uterine
canal. The uterus is sounded to document the size of the uterus and to confirm the uterine
position. The sound is held between the thumb and the index finger to avoid application of
excessive pressure. In some cases, dilation of the cervix may be required before sounding the
uterus. A normal uterus sounds to approximately 8 to 9 cm.

The pregnant uterus, however, should never be sounded because of the high risk for uterine
perforation. (See "Uterine perforation during gynecologic procedures".)
Cervical dilation After sounding the uterus, the cervix is dilated. The most common dilators
are the Pratt and Hegar (picture 5). The Pratt dilator comes in sizes ranging from 13 to 43
French; each French unit is equivalent to 0.33 mm in diameter. It is characterized by a gradual
taper at the end of the instrument. By comparison, Hegar dilators have a blunt end and come in
sizes ranging from 1 to 26 mm in diameter. We prefer the tapered end of the Pratt dilator to the
Hegar dilator. The former has been shown to require less force for dilation and is less likely to
cause a perforation of the uterus [14].
The dilator is grasped in the middle of the instrument with the thumb and index finger (figure 2).
The cervix is gradually dilated beginning with the #13 French Pratt dilator. The dilator should be
inserted through the internal os, without entering the uterine cavity excessively. This is helpful in
preventing uterine perforation and avoids damage to the endometrium, which obscures optimal
visualization if hysteroscopic examination is also planned.
The degree of cervical dilation is dependent upon the indication for the procedure. When
diagnostic hysteroscopy and D&C are performed, the dilation is conducted to a point at which
the hysteroscope may be comfortably inserted. The #17 French Pratt dilator will easily
accommodate a 5 mm hysteroscope or a #3 sharp curette.
When products of conception are to be removed, the cervix is generally dilated to a diameter in
millimeters equal to the gestational age of the uterus. Dilation is easily accomplished up to 9
mm, at which time the cervix may become difficult to dilate [15]. When cervical dilation beyond 9
mm is required (eg, second trimester pregnancy termination or operative hysteroscopy), osmotic
dilators should be placed preoperatively to allow gradual, atraumatic cervical dilation to occur.
(See "Overview of pregnancy termination", section on 'Osmotic dilators'.)
Cervical ripening agents (prostaglandins) may facilitate dilation. (See "Overview of
hysteroscopy", section on 'Cervical preparation and dilation'.)

Complicated cases A stenotic cervical os is often present in postmenopausal patients and

sometimes in women who have had previous cervical surgery. Stenosis increases the risk of
both cervical laceration and uterine perforation; therefore, these women are best dilated
beginning with a series of small (1 to 4 mm) Hegar dilators.
Having multiple types of cervical dilators available enables the surgeon to find the optimal
instrument to approach each specific clinical scenario. Tiny metal lacrimal duct probes are
useful for identifying the cervical canal in women with severe stenosis. Also, if the os is tightly
scarred, penetration of the external dimple with a number 11 scalpel blade facilitates much
easier passage of dilators without undue force. Care must be taken to excise on the external
dimple and not incise further into cervical tissue. Tapered Teflon dilators permit gradual and
gentle dilation of a stenotic cervical canal. The instrument should be inserted far enough to
reach the full diameter at the internal os, but no further. Deep insertion of dilators presents a
significant risk for perforation at the fundus, especially in a patient who is pregnant, postpartum,
or breastfeeding patient. If dilators do not pass with gentle pressure, the surgeon should stop
and reassess the uterine position, the amount of cervical traction, and the direction of insertion.
Transabdominal ultrasound can be useful to guide a difficult dilation and may be prudent in
women with a previous perforation of the uterus [16]. This technique is especially useful in
completing a D&C if a perforation is suspected or if there is a question as to the adequacy of the
evacuation. Rarely, it may be necessary to perform a conization to open the cervical canal.
Curettage
Curettes Metal curettes are available in blunt and sharp styles, ranging in size from #1 to #6,
with 1 being the smallest (picture 6). The curette is malleable, which allows the instrument to be
bent slightly to conform to the ante- or retro-flexed uterus.
Sharp curettes are typically used for gynecologic procedures, including first trimester pregnancy
termination. The blunt curette is best suited for the removal of small fragments of retained
products of conception in the second trimester and for the term postpartum uterus, and is often
used after suction curettage. The blunt edge prevents excessive removal of the basalis layer of

the endometrium, which can occur in the soft postpartum uterus and lead to formation of
intrauterine adhesions. (See 'Intrauterine adhesions' below.)
Plastic suction curettes are used for initial removal of products of conception from the uterus.
Some surgeons also prefer the suction curette for diagnostic curettage [17]. Suction curettes
range in size from 2 to 16 mm in diameter. Curettes 6 mm are flexible while the larger curettes
are rigid (picture 7). We prefer 6 to 8 mm curettes when performing suction curettage in a small
uterus (less than 8 week size). When a larger rigid suction curette is used, the curved
instrument provides better tactile sensation compared to the straight curette.
Sharp curettage Curettage is performed systematically beginning at the fundus. Even
pressure is applied to the endometrial surface along the entire length of the uterus from the
fundus to the internal cervical os (figure 3). The endometrial tissue is deposited on a Telfa pad,
which should be placed in the vagina to catch any spillage. The entire surface of the
endometrium is sampled by moving around the uterus in a consistent and systematic fashion.
The curettage procedure is completed when "uterine cry" (grittiness to palpation) is appreciated
on all surfaces of the uterus. The size and shape of any submucous fibroids detected by tactile
sensation should be noted as part of the operative note. Curettage followed by blind extraction
with Randall polyp forceps (picture 4) improves the rate of detection of polyps over curettage
alone [18].
A study evaluating the surface area sampled in 50 patients undergoing prehysterectomy D&C
found that less than one-fourth of the cavity had been curetted in 16 percent of specimens; less
than one-half of the cavity had been curetted in 60 percent; and less than three-quarters of the
cavity had been effectively curetted in 84 percent [19]. Despite these limitations, D&C provides
adequate sensitivity for detecting endometrial pathology because pathologic conditions usually
cover a large proportion of the surface area of the endometrial cavity and are therefore
detectable by sampling techniques. Focal pathologic processes may, however, go undetected by
any blind procedure. (See "Evaluation of the endometrium for malignant or premalignant
disease".)

Suction curettage
Diagnostic Suction curettage may be used for diagnostic purposes. The preferred
method uses the Pipelle device and is performed as an office procedure, usually without
anesthesia or cervical dilation. (See "Endometrial sampling procedures".)
The external cervical os is then checked for any evidence for excessive bleeding. The
tenaculum is removed and the cervix is examined for any trauma. Bleeding from the tenaculum
site generally responds to direct pressure or the application of ferric subsulfate solution
(Monsel's solution). Occasionally a suture or cautery is required.
Pregnant uterus Suction curettage is typically used for the evacuation of products of
conception, such as for incomplete or missed spontaneous abortion or for early
pregnancy termination. (See "Surgical termination of pregnancy: First trimester", section
on 'Curettage'.)
Large bore plastic cannulas (12 to 16 mm) are used for second trimester pregnancy termination
or removal of retained placental fragments/membranes postpartum. (See "Overview of secondtrimester pregnancy termination".) These cannulas should not be inserted deeply into the
pregnant or postpartum uterus due to the risk of perforation. Placing a hand on the fundus of the
uterus during the procedure may help to decrease the risk of perforation when the uterus is
large and assists with assessment of the changing uterine size and position. For the same
reason, it is preferable to explore the uterus with a large curette instead of narrower instruments,
such as forceps or a small suction cannula. Transabdominal ultrasound guidance is also an
option in this setting, but does require assistance from another provider or sonographer.
The cannula is rotated 360 degrees around its long axis under vacuum pressures of 50 to 60 cm
Hg. As tissue is evacuated, the uterus will contract and the suction curette may be advanced to
the fundus. Rotation is continued until no more tissue is drawn into the cannula. Oxytocin is
usually begun as soon as the suction curettage is started and continued for one or more hours
postoperatively. A few passes with a large blunt curette (eg, banjo curette) can be performed
after the suction procedure to remove any remaining products of conception.

Gestational trophoblastic neoplasia There are additional technical aspects of

curettage in this setting. (See "Hydatidiform mole: Management", section on 'Uterine
evacuation'.)
COMPLICATIONS Complications are rare and include:
Anesthesia related complications
Hemorrhage
Uterine perforation
Infection
Formations of intrauterine adhesions
Trophoblast embolization (if gestational trophoblastic disease present)
Uterine perforation Perforation of the uterus at the time of D&C is the most common
immediate complication. The rate of perforation varies with the indication for the procedure.
Perforation is most common when attempting control of postpartum hemorrhage (5.1 percent),
and is less frequent during diagnostic curettage (0.3 percent in the premenopausal patient and
2.6 percent in the postmenopausal patient) [20,21]. The risk of perforation is increased in
pregnancy due to softening of the uterine wall and the increased size of the endometrial cavity.
Uterine perforation is discussed in detail separately. (See "Uterine perforation during
gynecologic procedures".)
Cervical injury Cervical injuries can arise as a direct result of dilation or from trauma during
curettage. Cervical lacerations frequently occur when excessive traction is applied to the
tenaculum. The single tooth tenaculum is particularly vulnerable to such injuries; therefore, we
prefer the Bierer tenaculum.
Lacerations can be managed with direct pressure, application of ferric subsulfate solution,
cautery, or, in severe cases, suture control. Lacerations that involve the cervical branch of the
uterine artery can produce extensive hemorrhage that may be controlled with direct suture
application, by placing hemostatic sutures at the internal os, or therapeutic embolization. Rarely,

hysterectomy is required to control bleeding [22]. (See "Interventional radiology in management

of gynecological disorders".)
The risk of cervical injury can be reduced by avoiding use of excessive force during dilation. The
Pratt dilators generally require less force to insert into the cervix than Hegar dilators. Osmotic
dilators are helpful in decreasing the force required to dilate the cervix and are useful when
dilation of 9 mm or greater are anticipated. (See "Overview of pregnancy termination", section
on 'Osmotic dilators'.)
Infection Infection after dilation and curettage is rare. Although bacteremia has been
demonstrated after 5 percent of D&Cs, the incidence of septicemia is very low [23]. Very little is
known about risk factors for infection in patients undergoing D&C for diagnostic purposes. In
one study, the use of a rigid versus flexible cannula, general versus local anesthesia, and
resident versus attending physician were all associated with an increased risk of febrile
morbidity [24].
No data support the routine use of prophylactic antibiotics in diagnostic D&C, nor is subacute
bacterial endocarditis (SBE) prophylaxis recommended for a routine diagnostic D&C [25]. (See
"Antimicrobial prophylaxis for bacterial endocarditis".)
Intrauterine adhesions Approximately 90 percent of cases of severe intrauterine adhesive
disease are related to curettage for pregnancy complications, such as missed or incomplete
abortion, postpartum hemorrhage, or retained placental remnants [26,27]. (See "Intrauterine
adhesions".)
Trophoblastic embolization A rare complication of D&C of a molar pregnancy is
embolization of trophoblastic tissue into the systemic circulation [28]. Fatalities from
cardiovascular collapse due to trophoblastic embolization have been described [29]. Thyroid
storm is also encountered rarely. For these reasons, D&C for trophoblastic disease should be
performed in a formal operating room, with full anesthesia support and patient monitoring
available. (See "Initial management of low-risk gestational trophoblastic neoplasia".)

POSTOPERATIVE CARE AND FOLLOW-UP Patients may resume normal activities as soon
as the effects of anesthesia have worn off and they are comfortable.
Cramps are the most common side effect. They usually rapidly subside after the procedure, but
may last for a day or two. Nonsteroidal antiinflammatory drugs provide adequate analgesia.
Light bleeding can persist for several days. Heavy bleeding, such as saturating a sanitary pad
within one hour more than once, is abnormal.
The patient should call her provider if she develops fever (more than 100.4F), cramps lasting
longer than 48 hours, increasing pain, prolonged or heavy bleeding, or a foul-smelling vaginal
discharge.
Follow-up of patients with gestational trophoblastic disease is discussed separately. (See "Initial
management of low-risk gestational trophoblastic neoplasia".)
INFORMATION FOR PATIENTS UpToDate offers two types of patient education materials,
The Basics and Beyond the Basics. The Basics patient education pieces are written in plain
language, at the 5th to 6th grade reading level, and they answer the four or five key questions a
patient might have about a given condition. These articles are best for patients who want a
general overview and who prefer short, easy-to-read materials. Beyond the Basics patient
education pieces are longer, more sophisticated, and more detailed. These articles are written at
the 10th to 12th grade reading level and are best for patients who want in-depth information and
are comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print
or e-mail these topics to your patients. (You can also locate patient education articles on a
variety of subjects by searching on patient info and the keyword(s) of interest.)
Basics topics (see "Patient education: Dilation and curettage (D and C) (The Basics)")
Beyond the Basics topics (see "Patient education: Dilation and curettage (D and C)
(Beyond the Basics)")

SUMMARY AND RECOMMENDATIONS

Office based endometrial sampling, whenever feasible, is recommended over dilation
and curettage for diagnosis of abnormal uterine bleeding. (See 'Indications' above.)
If use of a large curette is planned, osmotic, rather than mechanical, cervical dilators
are recommended for cervical dilation greater than 9 mm. (See 'Cervical dilation' above.)
Sounding the pregnant uterus is not recommended because of the high risk of uterine
perforation. (See 'Sounding' above.)
In general, suction and blunt curettes are recommended for use in the pregnant or
postpartum uterus as they are less likely to cause uterine perforation or intrauterine
adhesions. Traditionally, sharp curettes are used in nonpregnant women, but suction or
blunt curettes are also acceptable. Endometrial pathology usually covers a large
proportion of the surface area of the endometrial cavity and is therefore detectable by
any of these sampling techniques, which have not been directly compared in randomized
trials. Focal pathologic processes may, however, go undetected by any blind procedure.
(See 'Curettage' above.)
Perforation of the fundus of the uterus is the most common immediate complication. It
should be suspected when there is a loss of resistance during instrumentation of the
uterus, when an instrument is found to extend into the uterine cavity for a distance that is
greater than the known depth of the uterus, or, obviously, if heavy bleeding or viscera are
observed in the vagina. Laparoscopy or laparotomy is often necessary to look for and
repair visceral or vascular injuries and to allow completion of the procedure under direct
vision. (See 'Uterine perforation' above.)
The blunt curette is recommended for use in the pregnant and postpartum uterus. The
blunt edge prevents excessive removal of the basalis layer of the endometrium, which
can lead to formation of intrauterine adhesions. (See 'Curettes' above and 'Intrauterine
adhesions' above.)
Use of UpToDate is subject to the Subscription and License Agreement.
REFERENCES

1.

Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to
Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing
Elective Procedures. www.asahq.org/publicationsAndServices/practiceparam.htm. (Accessed
on July 14, 2005).

2.

Zupi E, Luciano AA, Valli E, et al. The use of topical anesthesia in diagnostic
hysteroscopy and endometrial biopsy. Fertil Steril 1995; 63:414.

3.

Cicinelli E, Didonna T, Ambrosi G, et al. Topical anaesthesia for diagnostic hysteroscopy

and endometrial biopsy in postmenopausal women: a randomised placebo-controlled doubleblind study. Br J Obstet Gynaecol 1997; 104:316.

4.

Trolice MP, Fishburne C Jr, McGrady S. Anesthetic efficacy of intrauterine lidocaine for
endometrial biopsy: a randomized double-masked trial. Obstet Gynecol 2000; 95:345.

5.

Dogan E, Celiloglu M, Sarihan E, Demir A. Anesthetic effect of intrauterine lidocaine plus

naproxen sodium in endometrial biopsy. Obstet Gynecol 2004; 103:347.

6.

Rattanachaiyanont M, Leerasiri P, Indhavivadhana S. Effectiveness of intrauterine

anesthesia for pain relief during fractional curettage. Obstet Gynecol 2005; 106:533.

7.

Hui SK, Lee L, Ong C, et al. Intrauterine lignocaine as an anaesthetic during endometrial
sampling: a randomised double-blind controlled trial. BJOG 2006; 113:53.

8.

Lau WC, Tam WH, Lo WK, Yuen PM. A randomised double-blind placebo-controlled trial
of transcervical intrauterine local anaesthesia in outpatient hysteroscopy. BJOG 2000;
107:610.

9.

Frishman GN, Spencer PK, Weitzen S, et al. The use of intrauterine lidocaine to
minimize pain during hysterosalpingography: a randomized trial. Obstet Gynecol 2004;
103:1261.

10.

Kozman E, Collins P, Howard A, et al. The effect of an intrauterine application of two

percent lignocaine gel on pain perception during Vabra endometrial sampling: a randomised
double-blind, placebo-controlled trial. BJOG 2001; 108:87.

11.

Edelman A, Nichols MD, Leclair C, et al. Intrauterine lidocaine infusion for pain
management in first-trimester abortions. Obstet Gynecol 2004; 103:1267.

12.

Costello MF, Horrowitz S, Steigrad S, et al. Transcervical intrauterine topical local

anesthetic at hysterosalpingography: a prospective, randomized, double-blind, placebocontrolled trial. Fertil Steril 2002; 78:1116.

13.

Chen SS, Lee L. Reappraisal of endocervical curettage in predicting cervical

involvement by endometrial carcinoma. J Reprod Med 1986; 31:50.

14.

Hulka JF, Lefler HT Jr, Anglone A, Lachenbruch PA. A new electronic force monitor to
measure factors influencing cervical dilation for vacuum curettage. Am J Obstet Gynecol
1974; 120:166.

15.

Molin A. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by

suction aspiration. Gynecol Obstet Invest 1993; 35:152.

16.

Hunter RE, Reuter K, Kopin E. Use of ultrasonography in the difficult postmenopausal

dilation and curettage. Obstet Gynecol 1989; 73:813.

17.

Thompson JD, Rock J. Operative Gynecology, JB Lippincott, Philadelphia 1992.

18.

Gebauer G, Hafner A, Siebzehnrbl E, Lang N. Role of hysteroscopy in detection and

extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 2001;
184:59.

19.

Stock RJ, Kanbour A. Prehysterectomy curettage. Obstet Gynecol 1975; 45:537.

20.

Ben-Baruch G, Menczer J, Shalev J, et al. Uterine perforation during curettage:

perforation rates and postperforation management. Isr J Med Sci 1980; 16:821.

21.

Hefler L, Lemach A, Seebacher V, et al. The intraoperative complication rate of

nonobstetric dilation and curettage. Obstet Gynecol 2009; 113:1268.

22.

Lowensohn RI, Hibbard LT. Laceration of the ascending branch of the uterine artery: a
complication of therapeutic abortion. Am J Obstet Gynecol 1974; 118:36.

23.

Sacks PC, Tchabo JG. Incidence of bacteremia at dilation and curettage. J Reprod Med
1992; 37:331.

24.

Park TK, Flock M, Schulz KF, Grimes DA. Preventing febrile complications of suction
curettage abortion. Am J Obstet Gynecol 1985; 152:252.

25.

Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis.
Recommendations by the American Heart Association. JAMA 1990; 264:2919.

26.

March CM. Intrauterine adhesions. Obstet Gynecol Clin North Am 1995; 22:491.

27.

Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet
Gynecol Reprod Biol 1996; 65:109.

28.

Twiggs LB, Phillips GL. Documentation of subclinical trophoblastic embolization with

invasive cardiac monitoring in a woman with a molar pregnancy. A case report. J Reprod Med
1986; 31:277.

29.

Cohle SD, Petty CS. Sudden death caused by embolization of trophoblast from
hydatidiform mole. J Forensic Sci 1985; 30:1279.

Topic 3273 Version 12.0